Vanguard Group’s Fortress Biotech FBIO Stock Holding History

Vanguard Group’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$4.03M	Buy	1,100,570 +150,243	+16%	+$428K	﹤0.01%	3335
2025 Q3	$3.51M	Buy	950,327 +97,405	+11%	+$246K	﹤0.01%	3393
2025 Q2	$1.59M	Buy	852,922 +100,371	+13%	+$174K	﹤0.01%	3607
2025 Q1	$1.17M	Buy	752,551 +127,497	+20%	+$225K	﹤0.01%	3663
2024 Q4	$1.27M	Hold	625,054	–	–	﹤0.01%	3693
2024 Q3	$903K	Buy	625,054 +82,000	+15%	+$156K	﹤0.01%	3808
2024 Q2	$929K	Buy	543,054 +63,714	+13%	+$115K	﹤0.01%	3811
2024 Q1	$959K	Buy	479,340 +125,447	+35%	+$250K	﹤0.01%	3833
2023 Q4	$1.07M	Buy	353,893 +3,323	+0.9%	+$8.79K	﹤0.01%	3809
2023 Q3	$1.53M	Buy	350,570 +406	+0.1%	+$2.79K	﹤0.01%	3680
2023 Q2	$2.89M	Buy	350,164 +1,157	+0.3%	+$11.4K	﹤0.01%	3537
2023 Q1	$4.29M	Buy	349,007 +8,713	+3%	+$104K	﹤0.01%	3381
2022 Q4	$3.34M	Sell	340,294 -26	-0%	-$288	﹤0.01%	3474
2022 Q3	$4.39M	Sell	340,320 -1,794	-0.5%	-$26.9K	﹤0.01%	3394
2022 Q2	$4.31M	Sell	342,114 -36,189	-10%	-$536K	﹤0.01%	3453
2022 Q1	$7.72M	Sell	378,303 -1,049	-0.3%	-$28.7K	﹤0.01%	3288
2021 Q4	$14.2M	Buy	379,352 +19,680	+5%	+$878K	﹤0.01%	3029
2021 Q3	$17.4M	Buy	359,672 +1,489	+0.4%	+$72.7K	﹤0.01%	2941
2021 Q2	$19.2M	Buy	358,183 +15,282	+4%	+$922K	﹤0.01%	2868
2021 Q1	$18.2M	Buy	342,901 +38,356	+13%	+$2.16M	﹤0.01%	2837
2020 Q4	$14.5M	Buy	304,545 +86,453	+40%	+$3.74M	﹤0.01%	2800
2020 Q3	$13.2M	Buy	218,092 +68,029	+45%	+$3.47M	﹤0.01%	2649
2020 Q2	$6.03M	Buy	150,063 +30,137	+25%	+$1.12M	﹤0.01%	3019
2020 Q1	$3.4M	Buy	119,926 +9,270	+8%	+$308K	﹤0.01%	3136
2019 Q4	$4.27M	Sell	110,656 -6,491	-6%	-$167K	﹤0.01%	3215
2019 Q3	$2.48M	Sell	117,147 -23,692	-17%	-$557K	﹤0.01%	3380
2019 Q2	$3.17M	Buy	140,839 +55,901	+66%	+$1.44M	﹤0.01%	3326
2019 Q1	$2.27M	Buy	84,938 +12,550	+17%	+$329K	﹤0.01%	3409
2018 Q4	$934K	Sell	72,388 -10,815	-13%	-$181K	﹤0.01%	3582
2018 Q3	$2M	Buy	83,203 +1,760	+2%	+$56.3K	﹤0.01%	3526
2018 Q2	$3.64M	Buy	81,443 +1,052	+1%	+$59.2K	﹤0.01%	3317
2018 Q1	$5.49M	Sell	80,391 -1,521	-2%	-$96.3K	﹤0.01%	3105
2017 Q4	$4.9M	Buy	81,912 +2,360	+3%	+$139K	﹤0.01%	3143
2017 Q3	$5.27M	Sell	79,552 -6,512	-8%	-$439K	﹤0.01%	3100
2017 Q2	$6.13M	Sell	86,064 -7,098	-8%	-$419K	﹤0.01%	3013
2017 Q1	$5.17M	Buy	93,162 +4,506	+5%	+$202K	﹤0.01%	3041
2016 Q4	$3.59M	Sell	88,656 -721	-0.8%	-$27K	﹤0.01%	3175
2016 Q3	$3.98M	Sell	89,377 -319	-0.4%	-$13.6K	﹤0.01%	3117
2016 Q2	$3.62M	Buy	89,696 +6,083	+7%	+$283K	﹤0.01%	3125
2016 Q1	$3.89M	Hold	83,613	–	–	﹤0.01%	3096
2015 Q4	$3.5M	Buy	83,613 +1,648	+2%	+$69.1K	﹤0.01%	3149
2015 Q3	$3.2M	Buy	81,965 +1,080	+1%	+$50.5K	﹤0.01%	3163
2015 Q2	$4.08M	Buy	80,885 +1,624	+2%	+$83.3K	﹤0.01%	3108
2015 Q1	$4.58M	Buy	79,261 +1,554	+2%	+$64.8K	﹤0.01%	3039
2014 Q4	$2.84M	Buy	77,707 +12,202	+19%	+$359K	﹤0.01%	3149
2014 Q3	$2.06M	Buy	65,505 +5,327	+9%	+$141K	﹤0.01%	3255
2014 Q2	$1.55M	Sell	60,178 -2,609	-4%	-$68.8K	﹤0.01%	3362
2014 Q1	$1.86M	Buy	62,787 +20,415	+48%	+$796K	﹤0.01%	3256
2013 Q4	$1.67M	Buy	42,372 +8,964	+27%	+$346K	﹤0.01%	3259
2013 Q3	$3.52M	Buy	33,408 +1,087	+3%	+$133K	﹤0.01%	2913
2013 Q2	$4.17M	Buy	+32,321	New	+$4.77M	﹤0.01%	2764

Other funds holding FBIO

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

SAM

Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return